| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 125, 825-833, Copyright © 1989 by Endocrine Society
ARTICLES |
M Ernst, JK Heath and GA Rodan
Department of Bone Biology and Osteoporosis Research, Merck, Sharp, and Dohme Research Laboratories, West Point, Pennsylvania 19486.
Estradiol (E2) replacement therapy effectively prevents or delays postmenopausal bone loss, but the mode of E2 action on bone is still unknown. Recently, the presence of E2 receptors was described for bone- derived cells. In this study we examined the estrogen responsiveness of osteoblastic cells using the experimentally immortalized calvarial cell lines RCT-1 and RCT-3 as well as primary cultures of calvarial and trabecular bone cells. E2 treatment reduced PTH-stimulated adenylate cyclase activity by 20-30% in RCT cells; the maximum effect was observed after treatment with 1 nM E2 for 4 h or longer. In trabecular cells E2 decreased PTH-stimulated adenylate cyclase activity by 60-80%. After a lag period of at least 48 h, E2 treatment (0.01-10 nM) increased cell number and [3H]thymidine incorporation in both RCT-3 cells and primary cultures of trabecular cells to 20-60% above control values. Half-maximal effects were observed at about 1 nM E2. Antibodies against insulin-like growth factor-I (IGF-I) inhibited the E2-induced proliferation in a dose-dependent manner without affecting basal growth. Furthermore, E2 treatment increased the steady state levels of IGF-I mRNA 2- to 2.5-fold in calvarial and RCT-3 cells compared to control levels. In addition, E2 (10 nM) increased the level of collagen mRNA more than 2-fold and opposed the suppression of collagen mRNA produced by PTH treatment. The E2 effects were specific to 17 beta-E2, since they were not observed with the biologically less active stereoisomer 17 alpha-E2 and were blocked by the E2 antagonist tamoxifen (1 microM). Thus, for osteoblastic cells in culture, E2 can directly stimulate proliferation as well as collagen and IGF-I mRNA while decreasing PTH responsiveness; these effects could explain the anabolic and anticatabolic effects of E2 on bone.
This article has been cited by other articles:
 |
|
 |
|
  A. Giustina, G. Mazziotti, and E. Canalis Growth Hormone, Insulin-Like Growth Factors, and the Skeleton Endocr. Rev., August 1, 2008; 29(5): 535 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U.H. Lerner Bone Remodeling in Post-menopausal Osteoporosis Journal of Dental Research, July 1, 2006; 85(7): 584 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. M. Salih, S. Mohan, Y. Kasukawa, G. Tripathi, F. A. Lovett, N. F. Anderson, E. J. Carter, J. E. Wergedal, D. J. Baylink, and J. M. Pell Insulin-Like Growth Factor-Binding Protein-5 Induces a Gender-Related Decrease in Bone Mineral Density in Transgenic Mice Endocrinology, February 1, 2005; 146(2): 931 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Maccarinelli, V. Sibilia, A. Torsello, F. Raimondo, M. Pitto, A. Giustina, C. Netti, and D. Cocchi Ghrelin regulates proliferation and differentiation of osteoblastic cells J. Endocrinol., January 1, 2005; 184(1): 249 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Meier, P. Y. Liu, L. P. Ly, J. de Winter-Modzelewski, M. Jimenez, D. J. Handelsman, and M. J. Seibel Recombinant Human Chorionic Gonadotropin But Not Dihydrotestosterone Alone Stimulates Osteoblastic Collagen Synthesis in Older Men with Partial Age-Related Androgen Deficiency J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 3033 - 3041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A.A. Ewies, F. Al-Azzawi, and J. Thompson Changes in extracellular matrix proteins in the cardinal ligaments of post-menopausal women with or without prolapse: a computerized immunohistomorphometric analysis Hum. Reprod., October 1, 2003; 18(10): 2189 - 2195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Rivadeneira, J. J. Houwing-Duistermaat, N. Vaessen, J. M. Vergeer-Drop, A. Hofman, H. A. P. Pols, C. M. van Duijn, and A. G. Uitterlinden Association between an Insulin-Like Growth Factor I Gene Promoter Polymorphism and Bone Mineral Density in the Elderly: The Rotterdam Study J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3878 - 3884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Riggs, S. Khosla, and L. J. Melton III Sex Steroids and the Construction and Conservation of the Adult Skeleton Endocr. Rev., June 1, 2002; 23(3): 279 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lazar, A. Pertzelan, N. Weintrob, M. Phillip, and R. Kauli Sexual Precocity in Boys: Accelerated Versus Slowly Progressive Puberty Gonadotropin-Suppressive Therapy and Final Height J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4127 - 4132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Andress IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E283 - E288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Compston Sex Steroids and Bone Physiol Rev, January 1, 2001; 81(1): 419 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pfeilschifter and I. J. Diel Osteoporosis Due to Cancer Treatment: Pathogenesis and Management J. Clin. Oncol., April 7, 2000; 18(7): 1570 - 1593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. McCarthy, Changhua Ji, and M. Centrella Links Among Growth Factors, Hormones, and Nuclear Factors With Essential Roles in Bone Formation Critical Reviews in Oral Biology & Medicine, January 1, 2000; 11(4): 409 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Van Wyk Insulin-Like Growth Factors and Skeletal Growth: Possibilities for Therapeutic Interventions J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4349 - 4354. [Full Text]
|
|
|
|
|
|
A. B. Grayeli, O. Sterkers, P. Roulleau, P. Elbaz, E. Ferrary, and C. Silve Parathyroid hormone-parathyroid hormone-related peptide receptor expression and function in otosclerosis Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1005 - E1012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gohel, M.-B. McCarthy, and G. Gronowicz Estrogen Prevents Glucocorticoid-Induced Apoptosis in Osteoblasts in Vivo and in Vitro Endocrinology, November 1, 1999; 140(11): 5339 - 5347. [Abstract] [Full Text]
|
|
|
|
|
|
P. Garnero, Y. Tsouderos, I. Marton, C. Pelissier, C. Varin, and P. D. Delmas Effects of Intranasal 17{beta}-Estradiol on Bone Turnover and Serum Insulin-Like Growth Factor I in Postmenopausal Women J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2390 - 2397. [Abstract] [Full Text]
|
|
|
|
|
|
T. Seck, B. Scheppach, S. Scharla, I. Diel, W. F. Blum, H. Bismar, G. Schmid, B. Krempien, R. Ziegler, and J. Pfeilschifter Concentration of Insulin-Like Growth Factor (IGF)-I and -II in Iliac Crest Bone Matrix from Pre- and Postmenopausal Women: Relationship to Age, Menopause, Bone Turnover, Bone Volume, and Circulating IGFs J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2331 - 2337. [Abstract] [Full Text]
|
|
|
|
|
|
E.-L. Hietala, M. Larmas, and T. Salo Localization of Estrogen-receptor-related Antigen in Human Odontoblasts Journal of Dental Research, June 1, 1998; 77(6): 1384 - 1387. [Abstract] [PDF]
|
|
|
|
|
|
P. V. N. Bodine, R. A. Henderson, J. Green, M. Aronow, T. Owen, G. S. Stein, J. B. Lian, and B. S. Komm Estrogen Receptor-{alpha} Is Developmentally Regulated during Osteoblast Differentiation and Contributes to Selective Responsiveness of Gene Expression Endocrinology, April 1, 1998; 139(4): 2048 - 2057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Tau, T. E. Hefferan, K. M. Waters, J. A. Robinson, M. Subramaniam, B. L. Riggs, and T. C. Spelsberg Estrogen Regulation of a Transforming Growth Factor-{beta} Inducible Early Gene That Inhibits Deoxyribonucleic Acid Synthesis in Human Osteoblasts Endocrinology, March 1, 1998; 139(3): 1346 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ohlsson, B.-A. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg Growth Hormone and Bone Endocr. Rev., February 1, 1998; 19(1): 55 - 79. [Abstract] [Full Text]
|
|
|
|
|
|
R. S. Weinstein, R. L. Jilka, A. M. Parfitt, and S. C. Manolagas The Effects of Androgen Deficiency on Murine Bone Remodeling and Bone Mineral Density Are Mediated via Cells of the Osteoblastic Lineage Endocrinology, September 1, 1997; 138(9): 4013 - 4021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Liu, R. A. Al-Shaikh, V. Panossian, G. A. M. Finerman, and J. M. Lane Estrogen Affects the Cellular Metabolism of the Anterior Cruciate Ligament: A Potential Explanation for Female Athletic Injury Am. J. Sports Med., September 1, 1997; 25(5): 704 - 709. [Abstract] [PDF]
|
|
|
|
 |
|
 T. L. McCarthy, C. Ji, H. Shu, S. Casinghino, K. Crothers, P. Rotwein, and M. Centrella 17beta -Estradiol Potently Suppresses cAMP-induced Insulin-like Growth Factor-I Gene Activation in Primary Rat Osteoblast Cultures J. Biol. Chem., July 18, 1997; 272(29): 18132 - 18139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Robinson, S. A. Harris, B. L. Riggs, and T. C. Spelsberg Estrogen Regulation of Human Osteoblastic Cell Proliferation and Differentiation Endocrinology, July 1, 1997; 138(7): 2919 - 2927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Vered, I. Kaiserman, B.-A. Sela, and J. Sack Cross Genotype Sex Hormone Treatment in Two Cases of Hypogonadal Osteoporosis J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 576 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jilka, G Hangoc, G Girasole, G Passeri, D. Williams, J. Abrams, B Boyce, H Broxmeyer, and S. Manolagas Increased osteoclast development after estrogen loss: mediation by interleukin-6 Science, July 3, 1992; 257(5066): 88 - 91. [Abstract] [PDF]
|
|
|
|
|
|
B. Fournier, S. Gutzwiller, T. Dittmar, G. Matthias, P. Steenbergh, and P. Matthias Estrogen Receptor (ER)-alpha , but Not ER-beta , Mediates Regulation of the Insulin-like Growth Factor I Gene by Antiestrogens J. Biol. Chem., September 14, 2001; 276(38): 35444 - 35449. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
